Delivery Order SPE2DB22D2005-SPE2DB25FJQZ4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and is...
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $11,078.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 11, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical supplier to federal...
- The Defense Logistics Agency awarded a $1,865.83 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order is non-set-aside and represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a $3,453.76 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,086.58 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a $3,169.95 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a ceiling value of $8,630.84. This firm fixed-price delivery order, which is set to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The medication will be fulfilled from...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQZ4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,473.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on August 6, 2025, with completion targeted for August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for Trulicity, a diabetes medication, exemplifies the company's ongoing role in fulfilling specialized pharmaceutical requirements across multiple therapeutic domains for federal military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/6/25 |